Same-Day AST Starts With Faster Access to Viable Pellets
Faster access to viable microorganisms can influence whether downstream susceptibility testing begins today or tomorrow.
Antimicrobial susceptibility testing timelines are influenced long before an instrument begins its run. One of the earliest constraints is whether the laboratory can access viable microorganisms quickly enough to begin downstream work on the same day.
The front-end constraint
Conventional preparation often depends on plate inoculation and overnight incubation before sufficient colonies are available. That waiting period can push identification and susceptibility work into the following day, even when the original sample has already signalled a clinically important result.
Why a viable pellet matters
QUICKprep is designed to help laboratory professionals recover a pellet containing viable microorganisms in approximately five minutes. The recovered material can then be resuspended and adjusted to the concentration required by the intended downstream method.
Faster access to a viable microorganism pellet can create more opportunities to begin downstream testing on the same day.
From preparation to testing
The preparation step does not perform identification or AST itself. It creates a defined starting material for compatible workflows, including methods that require viable microorganisms at a standardized concentration.
In FASTINOV’s flow-cytometry AST research, prepared microorganism suspensions supported reported susceptibility results in under two hours. These workflow outcomes are supporting functional evidence and should not be interpreted as direct estimates of QUICKprep’s primary preparation-success endpoint.
A practical workflow question
For each laboratory, the relevant question is how quickly a positive sample can become useful material for the next microbiology step. Reducing the wait before that handoff can help preserve more options for same-day progress.